Update: Pneumococcal Polysaccharide Vaccine Usage—United States
Journal: Annals of Internal Medicine (1984)

Diagnosis and Treatment1 September 1984Update: Pneumococcal Polysaccharide Vaccine Usage—United StatesRecommendations of the Immunization Practices Advisory CommitteeAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-101-3-348 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail AbstractAbstractThese revised recommendations of the Immunization Practices Advisory Committee on pneumococcal polysaccharide vaccine update the previous recommendations (MMWR. 1981;30:410-2, 417-9) to include current information and practices.References1. BROOMEFACKLAM CR. Epidemiology of clinically significant isolates of Streptococcus pneumoniae in the United States. Rev Infect Dis. 1981;3:277-81. CrossrefMedlineGoogle Scholar2. ROBBINSAUSTRIANLEE JRC. Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis. 1983;148:1136-59. CrossrefMedlineGoogle Scholar3. PANKEYSCHIFFMAN GG. The immunogenicity and reactogenicity of a 22 valent pneumonococcal vaccine [Abstract]. Clin Res. 1982;30:376A. Google Scholar4. AUSTRIANDOUGLASSCHIFFMAN RRG. Prevention of pneumococcal pneumonia by vaccination. Trans Assoc Am Physicians. 1976;89:184-94. MedlineGoogle Scholar5. RILEYTARRANDREWS IPM. Immunisation with a polyvalent pneumococcal vaccine: reduction of adult respiratory mortality in a New Guinea Highlands community. Lancet. 1977;1:1338-41. CrossrefMedlineGoogle Scholar6. AUSTRIAN R. Surveillance of pneumococcal infection for field trials of polyvalent pneumococcal vaccines. Bethesda, Maryland: National Institutes of Health; 1980. (Report DAB-VDP-12-84.) Google Scholar7. BROOMEFACKLAMFRASER CRD. Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine. N Engl J Med. 1980;303:549-52. CrossrefMedlineGoogle Scholar8. SHAPIROCLEMENS EJ. A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk for serious pneumonia infections. Ann Intern Med. 1984;101:325-30. LinkGoogle Scholar9. AMMANNADDIEGOWARALUBINSMITHMENTZER AJDBWW. Polyvalent pneumococcal-polysaccharide immunization of patients with sickle-cell anemia and patients with splenectomy. N Engl J Med. 1977;297:897-900. CrossrefMedlineGoogle Scholar10. KLEINTEELESLOYER JDJ. Use of pneumococcal vaccine for prevention of recurrent episodes of otitis media. In: WEINSTEIN L, FIELDS BN, eds. Seminars in Infectious Disease. New York: Thieme-Stratton Inc: 1982:305-10. Google Scholar11. FEDSONCHIARELLO DL. Previous hospital care and pneumococcal bacteremia: importance for pneumococcal immunization. Arch Intern Med. 1983;143:885-9. CrossrefMedlineGoogle Scholar12. DESTEFANOGOODMANNOBLEMCCLARYSMITHBROOME FRGGSC. Simultaneous administration of influenza and pneumococcal vaccines. JAMA. 1982;247:2551-4. CrossrefGoogle Scholar13. SEMELSESKIND JC. Severe febrile reaction to pneumococcal vaccine [Letter]. JAMA. 1979;241:1792. CrossrefMedlineGoogle Scholar14. SCHWARTZ J. Pneumococcal vaccine: clinical efficacy and effectiveness. Ann Intern Med. 1982;96:208-20. LinkGoogle Scholar15. BORGONOMCLEANVELLA JAP. Vaccination and revaccination with polyvalent pneumococcal polysaccharide vaccines in adults and infants (40010). Proc Soc Exp Biol Med. 1978;157:148-54. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: ▸From the Immunization Practices Advisory Committee, Centers for Disease Control; Atlanta, Georgia. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byPneumococcal Polysaccharide VaccinesImmunological evaluation of the entirely carbohydrate-based Thomsen-Friedenreich – PS B conjugateImmunodeficiency and Invasive Pneumococcal DiseasePneumococcal polysaccharide vaccinesResponse to conjugate pneumococcal and Haemophilus influenzae type b vaccines in asplenic patientsPneumococcal polysaccharide vaccinesInvasive Pneumococcal Disease in the Immunocompromised HostPractical Use of Vaccines to Prevent Infection with Influenza Virus and Streptococcus pneumoniaePneumococcal vaccination for patients with spinal cord injuryPathophysiology of pulmonary defense mechanismsVaccination of the Dialysis PatientImmunogenicity and immunochemistry ofStreptococcus pneumoniae capsular polysaccharidesTreatment of childhood bacterial meningitisHost Defenses and Infectious Complications in Maintenance Hemodialysis PatientsHigh rates of immunization in a nursing homePneumococcal bacteremia in cancer patientsThe effect of pneumococcal vaccine on the disposition of theophyllineStrategies for the Prevention of PneumoniaPneumococcal serotypes in sputum isolates during acute respiratory illness in Edinburgh.Recurrent meningitis: A case reportEpidemiology as a Liberal ArtOverwhelming pneumoniaPneumococcal intracellular killing is abolished by polysaccharide despite serum complement activityPneumococcal Pneumonia; Diagnostic, Epidemiologic, Therapeutic and Prophylactic ConsiderationsPneumonia in the ElderlyImmunizing the adultPneumococcal Vaccine and Patients with Chronic Lung DiseaseJAMES H. WILLIAMS Jr., M.D., KENNETH M. MOSER, M.D.Persistence of antibodies to pneumococcal vaccine in patients with chronic renal failureThe need for sexual assault centres in the UKPneumococcal bacteraemiaPneumococcal bacteraemiaCefotaxime in pneumococcal meningitisHost Defenses and Infectious Complications in Maintenance Hemodialysis Patients 1 September 1984Volume 101, Issue 3Page: 348-350KeywordsPolysaccharidesVaccines ePublished: 1 December 2008 Issue Published: 1 September 1984 PDF downloadLoading ...